For generations, osteoarthritis has been framed as the body's slow surrender to time and motion — cartilage worn thin, pain managed but never truly addressed. New research published in Genes & Diseases reframes this understanding, revealing that a molecular communication network called purinergic signaling actively governs how joints deteriorate, and that selectively tuning its receptors may offer a path not merely to relief, but to genuine disease modification. For the millions worldwide whose daily lives are shaped by stiff, aching joints, this distinction — between managing decline and inte
Purinergic Signaling Offers New Path to Treating Osteoarthritis Beyond Pain Relief
Osteoarthritis affects millions worldwide as a leading cause of pain and disability, impacting quality of life and work capacity.